SLIRP Antikörper (N-Term)
Kurzübersicht für SLIRP Antikörper (N-Term) (ABIN633258)
Target
Alle SLIRP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- C14 ORF156 antibody was raised against the N terminal Of C14 rf156
-
Aufreinigung
- Affinity purified
-
Immunogen
- C14 ORF156 antibody was raised using the N terminal Of C14 rf156 corresponding to a region with amino acids PFDKETGFHRGLGWVQFSSEEGLRNALQQENHIIDGVKVQVHTRRPKLPQ
-
-
-
-
Applikationshinweise
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
C14ORF156 Blocking Peptide, (ABIN5612410), is also available for use as a blocking control in assays to test for specificity of this C14ORF156 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C10 RF156 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SLIRP (SRA Stem-Loop Interacting RNA Binding Protein (SLIRP))
-
Andere Bezeichnung
- C14ORF156
-
Hintergrund
- As a RNA-binding protein, C14orf156 acts as a nuclear receptor corepressor. It probably acts by binding the SRA RNA, and repressing the SRA-mediated nuclear receptor coactivation. C14orf156 binds the STR7 loop of SRA RNA. It is also able to repress glucocorticoid (GR), androgen (AR), thyroid (TR) and VDR-mediated transactivation.
-
Molekulargewicht
- 12 kDa (MW of target protein)
Target
-